TLR7
Basic information
Region (hg38): X:12867072-12890361
Links
Phenotypes
GenCC
Source:
- immunodeficiency 74, COVID-19-related, X-linked (Limited), mode of inheritance: Unknown
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Immunodeficiency 74, COVID-19 related, X-linked | XL | Allergy/Immunology/Infectious | Individuals with Immunodeficiency 74, COVID-19 related, X-linked, may demonstrate susceptibility to severe COVID-19, and awareness may allow preventative measures (such as adhering to practices to reduce the chance of infection); Individuals with Systemic lupus erythematosus have been described as benefiting from medical management (eg, with prednisone, azathioprine, mycophenolate, rituximab, immunoglobulins, Etanercept) | Allergy/Immunology/Infectious | 32706371; 35477763 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TLR7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 70 | 12 | 82 | |||
missense | 103 | 110 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 109 | 75 | 14 |
Variants in TLR7
This is a list of pathogenic ClinVar variants found in the TLR7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-12885537-G-A | Uncertain significance (Jun 20, 2022) | |||
X-12885540-A-T | not specified | Benign (Feb 01, 2024) | ||
X-12885590-A-G | Systemic lupus erythematosus 17 | Pathogenic (May 10, 2022) | ||
X-12885591-G-T | Uncertain significance (Dec 02, 2023) | |||
X-12885592-A-G | Likely benign (May 17, 2023) | |||
X-12885616-T-C | Likely benign (Nov 02, 2023) | |||
X-12885631-T-G | Uncertain significance (Nov 28, 2023) | |||
X-12885639-A-G | not specified | Uncertain significance (Apr 06, 2024) | ||
X-12885652-C-T | Likely benign (May 15, 2023) | |||
X-12885692-G-A | Uncertain significance (Jun 27, 2022) | |||
X-12885701-A-G | Uncertain significance (Jan 25, 2024) | |||
X-12885703-G-A | Likely benign (May 19, 2022) | |||
X-12885730-T-G | Uncertain significance (Dec 25, 2023) | |||
X-12885753-C-T | not specified | Uncertain significance (Nov 12, 2021) | ||
X-12885756-C-T | Uncertain significance (Nov 18, 2023) | |||
X-12885757-G-A | Likely benign (Dec 13, 2023) | |||
X-12885774-A-G | not specified | Uncertain significance (Jun 02, 2023) | ||
X-12885776-C-T | Uncertain significance (Jan 28, 2023) | |||
X-12885782-G-A | TLR7-related disorder • not specified | Conflicting classifications of pathogenicity (Nov 13, 2023) | ||
X-12885790-C-T | Likely benign (Mar 01, 2023) | |||
X-12885802-C-T | Likely benign (Jul 12, 2023) | |||
X-12885811-A-G | Likely benign (Feb 21, 2023) | |||
X-12885840-T-C | Uncertain significance (Sep 04, 2023) | |||
X-12885845-A-T | Uncertain significance (Dec 13, 2023) | |||
X-12885857-C-A | not specified | Uncertain significance (Mar 01, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TLR7 | protein_coding | protein_coding | ENST00000380659 | 2 | 23298 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.979 | 0.0209 | 125735 | 4 | 5 | 125744 | 0.0000358 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.01 | 205 | 368 | 0.558 | 0.0000261 | 6976 |
Missense in Polyphen | 42 | 127.94 | 0.32828 | 2454 | ||
Synonymous | -0.527 | 157 | 149 | 1.05 | 0.0000109 | 2020 |
Loss of Function | 3.80 | 2 | 20.7 | 0.0968 | 0.00000143 | 428 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000113 | 0.0000981 |
Ashkenazi Jewish | 0.000268 | 0.000198 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000244 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.000169 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Key component of innate and adaptive immunity. TLRs (Toll-like receptors) control host immune response against pathogens through recognition of molecular patterns specific to microorganisms. TLR7 is a nucleotide-sensing TLR which is activated by single-stranded RNA. Acts via MYD88 and TRAF6, leading to NF-kappa-B activation, cytokine secretion and the inflammatory response (By similarity). {ECO:0000250, ECO:0000269|PubMed:18250417}.;
- Pathway
- Influenza A - Homo sapiens (human);Toll-like receptor signaling pathway - Homo sapiens (human);Measles - Homo sapiens (human);Regulation of toll-like receptor signaling pathway;Toll-like Receptor Signaling;Simplified Depiction of MYD88 Distinct Input-Output Pathway;Toll-like Receptor Signaling Pathway;Toll Like Receptor 7/8 (TLR7/8) Cascade;TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling;toll-like receptor pathway;Toll Like Receptor 9 (TLR9) Cascade;Trafficking and processing of endosomal TLR;Toll-Like Receptors Cascades;Innate Immune System;Immune System;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome
(Consensus)
Recessive Scores
- pRec
- 0.287
Intolerance Scores
- loftool
- 0.271
- rvis_EVS
- -0.4
- rvis_percentile_EVS
- 26.85
Haploinsufficiency Scores
- pHI
- 0.134
- hipred
- Y
- hipred_score
- 0.749
- ghis
- 0.571
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.122
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tlr7
- Phenotype
- cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; renal/urinary system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype;
Gene ontology
- Biological process
- microglial cell activation;regulation of protein phosphorylation;toll-like receptor signaling pathway;MyD88-dependent toll-like receptor signaling pathway;immune response;I-kappaB kinase/NF-kappaB signaling;I-kappaB phosphorylation;positive regulation of chemokine production;positive regulation of interleukin-6 production;positive regulation of interleukin-8 production;toll-like receptor 7 signaling pathway;toll-like receptor 9 signaling pathway;positive regulation of interferon-gamma biosynthetic process;innate immune response;positive regulation of interferon-alpha biosynthetic process;positive regulation of interferon-beta biosynthetic process;positive regulation of interleukin-8 biosynthetic process;positive regulation of inflammatory response;defense response to virus;cellular response to mechanical stimulus;positive regulation of NIK/NF-kappaB signaling
- Cellular component
- Golgi membrane;cytoplasm;lysosome;endosome;endoplasmic reticulum;endoplasmic reticulum membrane;plasma membrane;endosome membrane;integral component of membrane;early phagosome;endolysosome membrane;receptor complex
- Molecular function
- double-stranded RNA binding;single-stranded RNA binding;transmembrane signaling receptor activity;drug binding;signaling pattern recognition receptor activity;siRNA binding